Literature DB >> 14741982

Developing appropriate community-based postgraduate training in a developing country.

G W Brobby1, F O Ofosu-Barko.   

Abstract

The School of Medical Sciences, KNUST, established in 1975, indicated its educational orientation to a community-based and community-oriented system using the problem-based learning approach. Falling victim to the phenomenon of brain-drain, the School developed a postgraduate medical curriculum which takes into account the needs and demands of national governments and communities for quality specialist care and equitable distribution of existing health facilities. There is an innovative community-based fourth year for obstetrics and gynaecology, ophthalmology, otorhinolaryngology, paediatrics, surgery and medicine. After attainment of the Part I Examination, residents are sent to Ulm, Maastricht, Britain and the United States for clinical attachments for a period of 3 to 6 months before returning to sit for their Final Part II for the Fellowship of the West African College of Surgeons or Physicians (FWACS, FWACP). By ensuring that the Final Examinations take place after the elective attachment, none of the new breed of specialists so far produced has been lost to the Western world. The strengths and weaknesses of the programme are discussed.

Entities:  

Year:  2002        PMID: 14741982     DOI: 10.1080/13576280110107288

Source DB:  PubMed          Journal:  Educ Health (Abingdon)        ISSN: 1357-6283


  3 in total

1.  Career destinations of University of Ghana Medical School graduates of various year groups.

Authors:  A T Lassey; P D Lassey; M Boamah
Journal:  Ghana Med J       Date:  2013-06

2.  North-South surgical training partnerships: a systematic review.

Authors:  Tim Greive-Price; Hardee Mistry; Robert Baird
Journal:  Can J Surg       Date:  2020-11-30       Impact factor: 2.089

Review 3.  Systematic Review of Postgraduate Surgical Education in Low- and Middle-Income Countries.

Authors:  Jennifer Rickard
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.